Reimbursed Care Access in Saint Kitts and Nevis

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Saint Kitts and Nevis is a party to the 1971 Convention on Psychotropic Substances, which places psilocybin/psilocin among internationally controlled psychotropics; domestic prosecutions and the Drugs (Prevention of Misuse) Act (and case law applying it) implement those controls locally. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. MDMA is controlled under the 1971 Convention and enforced in domestic statutes; there is no public evidence of licensed medical/therapeutic MDMA programs or reimbursement in Saint Kitts and Nevis. # #.

Esketamine (branded Spravato) is an approved prescription medicine in multiple jurisdictions internationally but there is no public, authoritative record of national regulatory authorization or public reimbursement for Spravato in Saint Kitts and Nevis as of February 20, 2026; therefore it is not part of routine publicly reimbursed mental‑health care in the federation. Licensed esketamine products are normally subject to strict distribution and monitoring (REMS/Risk‑management) where approved internationally; any local use would require national regulatory approval, import authorization, and facility procedures for supervised administration — none of which are publicly documented for Saint Kitts and Nevis in national registries or manufacturer country‑lists consulted. For context, Spravato is marketed and approved in many countries under REMS/Risk‑management programs (manufacturer communications). # #.

Ketamine is an established, licenced anaesthetic and analgesic available within health systems worldwide and is listed on the WHO Model List of Essential Medicines as an injectable anesthetic; as such it is used in hospital and clinic settings in Saint Kitts and Nevis for approved anaesthesia/analgesia indications and can be lawfully possessed and administered by authorised health professionals. Off‑label use of ketamine (for example, repeated sub‑anesthetic infusions for depression) is a clinical practice in some jurisdictions but requires local clinical governance, institutional approval, and (where applicable) private‑pay arrangements — there is no evidence of public reimbursement for ketamine infusions for psychiatric indications in Saint Kitts and Nevis. Regulatory criminal law controls remain in force for non‑medical possession or supply. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. DMT (and many plant mixtures containing it) are globally controlled under international conventions and are incorporated into domestic controlled‑substances frameworks applied by Saint Kitts and Nevis. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. 5‑MeO‑DMT falls under the same international/domestic control frameworks as other tryptamine psychedelics and is not legally available outside approved research. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no authorized medical ibogaine treatment program or public reimbursement in Saint Kitts and Nevis. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Plant‑based preparations containing DMT (ayahuasca) are treated under the same controlled‑substance rules as isolated DMT; traditional/ceremonial claims do not provide legal authorization absent specific national exemptions—which are not documented for Saint Kitts and Nevis. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mescaline (including peyote/mescaline‑containing cacti) is internationally controlled and is captured by domestic controlled‑drugs statutes in Saint Kitts and Nevis; no medical licensing pathway or public reimbursement for mescaline therapy is evident. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. The 2C‑family of substituted phenethylamines are typically controlled under broad domestic scheduling provisions derived from international obligations; there is no authorized therapeutic or reimbursed access in Saint Kitts and Nevis. # #.